In this regard, several case reports have shown that using dupilumab, a monoclonal antibody targeting IL-4 and IL-13, successfully resolves BP [30,47], in addition to pemphigus vulgaris [48]. This evidence concerns the gene IL4 and pemphigus vulgaris.